×
Yubo Biotech Total Liabilities 2010-2024 | YBGJ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Yubo Biotech total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
View More
Yubo Biotech Total Liabilities 2010-2024 | YBGJ
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Total Assets
Cash on Hand
Long Term Debt
Total Liabilities
Share Holder Equity
Yubo Biotech total liabilities from 2010 to 2024. Total liabilities can be defined as the total value of all possible claims against the corporation.
Related Stocks
Company Name
Market
Cap
Thermo Fisher Scientific (TMO)
$236.9B
Intuitive Surgical (ISRG)
$174.1B
Alcon (ALC)
$48.5B
IQVIA Holdings (IQV)
$44.6B
IDEXX Laboratories (IDXX)
$42.6B
Edwards Lifesciences (EW)
$40.5B
DexCom (DXCM)
$28.8B
STERIS (STE)
$23.6B
SONOVA HOLDING (SONVY)
$21B
Waters (WAT)
$20.1B
Hologic (HOLX)
$19.1B
Sysmex ADR (SSMXY)
$12.5B
Fresenius Medical Care AG KGaA (FMS)
$12.2B
Teleflex (TFX)
$11.6B
Globus Medical (GMED)
$9.6B
Penumbra (PEN)
$7.8B
Glaukos (GKOS)
$7.1B
Masimo (MASI)
$5.9B
TransMedics (TMDX)
$5.5B
Integer Holdings (ITGR)
$4.4B
PROCEPT BioRobotics (PRCT)
$4.3B
Tandem Diabetes Care (TNDM)
$2.9B
LivaNova (LIVN)
$2.8B
Veracyte (VCYT)
$2.7B
Inari Medical (NARI)
$2.6B
Elekta AB (EKTAY)
$2.5B
Nihon Kohden (NHNKY)
$2.3B
RxSight (RXST)
$2B
Integra LifeSciences Holdings (IART)
$1.4B
Pulse Biosciences (PLSE)
$1.1B